97 related articles for article (PubMed ID: 11101807)
1. Breeding of retroviruses by DNA shuffling for improved stability and processing yields.
Powell SK; Kaloss MA; Pinkstaff A; McKee R; Burimski I; Pensiero M; Otto E; Stemmer WP; Soong NW
Nat Biotechnol; 2000 Dec; 18(12):1279-82. PubMed ID: 11101807
[TBL] [Abstract][Full Text] [Related]
2. Molecular breeding of viruses.
Soong NW; Nomura L; Pekrun K; Reed M; Sheppard L; Dawes G; Stemmer WP
Nat Genet; 2000 Aug; 25(4):436-9. PubMed ID: 10932190
[TBL] [Abstract][Full Text] [Related]
3. Viral vectors do the DNA shuffle.
Miyanohara A; Friedmann T
Nat Biotechnol; 2000 Dec; 18(12):1244-5. PubMed ID: 11101799
[No Abstract] [Full Text] [Related]
4. An essential role for the His-8 residue of the SDF-1alpha-chimeric, tropism-redirected Env protein of the Moloney murine leukemia virus in regulating postbinding fusion events.
Katane M; Fujita R; Takao E; Kubo Y; Aoki Y; Amanuma H
J Gene Med; 2004 Mar; 6(3):260-7. PubMed ID: 15026987
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary studies on the design of retroviral vectors for substitutive gene therapy].
Martín F; Jean-Mairet Y; Talavera A
Microbiologia; 1996 Mar; 12(1):43-50. PubMed ID: 9019133
[TBL] [Abstract][Full Text] [Related]
6. Capsid-targeted viral inactivation can eliminate the production of infectious murine leukemia virus in vitro.
VanBrocklin M; Federspiel MJ
Virology; 2000 Feb; 267(1):111-23. PubMed ID: 10648188
[TBL] [Abstract][Full Text] [Related]
7. Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line.
Garrett E; Miller AR; Goldman JM; Apperley JF; Melo JV
Virology; 2000 Jan; 266(1):170-9. PubMed ID: 10612671
[TBL] [Abstract][Full Text] [Related]
8. Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry.
Viejo-Borbolla A; Pizzato M; Blair ED; Schulz TF
Virus Res; 2005 Mar; 108(1-2):45-55. PubMed ID: 15681054
[TBL] [Abstract][Full Text] [Related]
9. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
Sandrin V; Muriaux D; Darlix JL; Cosset FL
J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
[TBL] [Abstract][Full Text] [Related]
10. Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary.
Logg CR; Logg A; Tai CK; Cannon PM; Kasahara N
J Virol; 2001 Aug; 75(15):6989-98. PubMed ID: 11435579
[TBL] [Abstract][Full Text] [Related]
11. Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors.
Paar M; Schwab S; Rosenfellner D; Salmons B; Günzburg WH; Renner M; Portsmouth D
J Virol; 2007 Jul; 81(13):6973-83. PubMed ID: 17442710
[TBL] [Abstract][Full Text] [Related]
12. Construction of retroviral vectors with enhanced efficiency of transgene expression.
Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
[TBL] [Abstract][Full Text] [Related]
13. Identification of residues of the Moloney murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo.
Gonsky J; Bacharach E; Goff SP
J Virol; 2001 Mar; 75(6):2616-26. PubMed ID: 11222684
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery.
Ghani K; Cottin S; de Campos-Lima PO; Caron MC; Caruso M
J Gene Med; 2009 Aug; 11(8):664-9. PubMed ID: 19507185
[TBL] [Abstract][Full Text] [Related]
15. Fusoselect: cell-cell fusion activity engineered by directed evolution of a retroviral glycoprotein.
Merten CA; Stitz J; Braun G; Medvedovska J; Cichutek K; Buchholz CJ
Nucleic Acids Res; 2006; 34(5):e41. PubMed ID: 16540592
[TBL] [Abstract][Full Text] [Related]
16. Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells.
Finger C; Sun Y; Sanz L; Alvarez-Vallina L; Buchholz CJ; Cichutek K
Cancer Gene Ther; 2005 May; 12(5):464-74. PubMed ID: 15692609
[TBL] [Abstract][Full Text] [Related]
17. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
Zhao-Emonet JC; Marodon G; Pioche-Durieu C; Cosset FL; Klatzmann D
J Gene Med; 2000; 2(6):416-25. PubMed ID: 11199262
[TBL] [Abstract][Full Text] [Related]
18. Development of novel vaccines using DNA shuffling and screening strategies.
Locher CP; Soong NW; Whalen RG; Punnonen J
Curr Opin Mol Ther; 2004 Feb; 6(1):34-9. PubMed ID: 15011779
[TBL] [Abstract][Full Text] [Related]
19. Characterization of recombinant helper retroviruses from Moloney-based vectors in ecotropic and amphotropic packaging cell lines.
Scarpa M; Cournoyer D; Muzny DM; Moore KA; Belmont JW; Caskey CT
Virology; 1991 Feb; 180(2):849-52. PubMed ID: 1989392
[TBL] [Abstract][Full Text] [Related]
20. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
Sena-Esteves M; Hampl JA; Camp SM; Breakefield XO
J Gene Med; 2002; 4(3):229-39. PubMed ID: 12112640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
